InTandem Capital Partners Invests in Clinilabs
March 12, 2025
InTandem Capital Partners has made a strategic growth investment in Clinilabs, a global full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug and device development. The partnership with Clinilabs’ founder and management will support scaling the company’s neuroscience trial capabilities across Phase 1–3 and accelerate commercial and operational growth.
- Buyers
- InTandem Capital Partners
- Targets
- Clinilabs
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
InTandem Capital Partners Makes Growth Investment in Adams Clinical
May 21, 2024
Healthcare Services
InTandem Capital Partners, a healthcare-focused private equity firm, has partnered with the founders and management team of Adams Clinical, a Watertown, Massachusetts–based clinical trial site network focused on psychiatric and neurologic indications. The investment will support Adams Clinical’s growth and development of its site network and patient recruitment capabilities to better serve pharmaceutical sponsors and CROs.
-
Ampersand Capital Partners Invests in AnaBios Corporation
June 7, 2022
Healthcare Services
Ampersand Capital Partners has made a growth equity investment in San Diego-based AnaBios Corporation, a preclinical contract research organization specializing in translational research using human tissues. The investment will be used to expand AnaBios’s capabilities, therapeutic area coverage and global reach to support more successful drug discovery and development programs.
-
InTandem Capital Partners Acquires OrthoNebraska
August 3, 2023
Healthcare Services
InTandem Capital Partners completed a strategic equity investment to acquire OrthoNebraska, a regional provider of orthopedic and musculoskeletal care headquartered in Omaha, Nebraska. Audax Private Debt provided a unitranche credit facility to support the transaction; InTandem intends to accelerate OrthoNebraska's growth by expanding clinical capabilities and geographic reach.
-
InTandem Capital Makes Growth Investment in San Diego Fertility Center
March 3, 2021
Healthcare Services
InTandem Capital Partners (via its affiliated Fund II) completed a growth equity investment in San Diego Fertility Center to accelerate the clinic’s expansion and preserve its clinical culture. The partnership is intended to help SDFC expand nationally and pursue like-minded practices to join the platform while maintaining high-quality patient care.
-
Ampersand Capital Partners Majority Recapitalizes Julius Clinical Research
November 28, 2023
Healthcare Services
Ampersand Capital Partners has completed a majority recapitalization of Julius Clinical Research, a Zeist-based clinical CRO, to support geographic expansion and deepen the company's scientific and therapeutic expertise. The investment will help Julius grow its CRO services in CNS, renal, cardiometabolic and infectious disease areas and expand its footprint in Europe and North America.
-
InTandem Capital Partners Makes Growth Investment in Providence Care
January 19, 2022
Healthcare Services
InTandem Capital Partners completed a growth equity investment in Providence Care, a Rock Hill, South Carolina-based provider of post-acute and end-of-life services. The investment will support Providence Care's expansion plans and the firm has added Larry Nabb as CEO to accelerate growth; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.